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IntroductIon
Metabolic syndrome (MetS) is a clustering of several risk fac-
tors including hypertension, dyslipidemia, impaired glucose 
tolerance, and central adiposity. The clustering of those risk 
factors confers a higher risk of diabetes and cardiovascular dis-
ease (CVD). The most recent International Diabetes Federation 
(IDF) definition, similar to World Health Organization criteria, 
relies on an ordering of criteria as an abnormal waist circumfer-
ence (WC) must be present to satisfy for MetS (1,2); whereas the 
Adult Treatment Panel III (ATPIII) of the National Cholesterol 
Education Program proposed the definition of MetS as an 
abnormality in any three of five criteria (3) (Table 1).
The prevalence of MetS in adult Australians was 28.6% in 
1999–2000 in a nationally representative sample using the IDF 
definition (4). Indigenous Australians had higher rates where 
the ATPIII criteria classified 43% of Torres Strait Islander adults 
(TSIs) and 44% of Aborigines with MetS, compared to 32 and 
28%, respectively, according to World Health Organization 
criteria, from a cross-sectional survey in North Queensland 
during 1993–1995 (5). No studies in the Australian population 
have been published to date to study the prediction of MetS for 
CVD, although a meta-analysis of a dozen prospective stud-
ies from United States and European countries indicated MetS 
independently conferred a modest risk (hazard ratio (HR): 
1.3–1.7) of developing CVD, using both ATPIII of the National 
Cholesterol Education Program or World Health Organization 
criteria (6).
We have previously shown in this population that high base-
line prevalence of diabetes and albuminuria better predict 
incident CHD than the “traditional” Framingham risk factors 
alone: BMI, blood pressure (BP), smoking, and dyslipidemia 
(7). The aim of this analysis is to compare the prevalence of 
MetS using IDF and ATPIII criteria, and to explore the inde-
pendent prediction of components of MetS for developing 
CHD in two distinct Australian indigenous populations from 
North Queensland.
Methods and Procedures
Participants
The Well Persons Health Check (WPHC), conducted between 1998 
and 2000, offered screening and referral services for people in discrete 
indigenous communities in northern Queensland (8). A cohort of 2,100 
indigenous people aged ≥15 without pre-existing heart conditions was 
included in this study. The study was approved by the Cairns Base 
Hospital Ethics Committee with support from relevant peak Aboriginal 
and Torres Strait Islander Health Councils.
Baseline measurements
Details of the methods used in the WPHC have been published else-
where (8). WC was recorded to the nearest centimeter with the latter 
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measured by the same technician at the level of the umbilicus. Smoking 
and alcohol intake was assessed by self-report questionnaire (9). Total 
cholesterol, high-density lipoprotein (HDL), low-density lipoprotein 
(LDL), triglycerides, and glucose were measured from the blood of 
all participants after at least 8 hours fast. The blood was collected by a 
medical officer, registered nurse, or trained phlebotomist in the early 
morning. Blood glucose and blood lipids were measured using pho-
tometric enzyme end point assay with Cobas Integra 700/400 (Roche 
Diagnostics, Rotkreuz, Switzerland). Albumin:creatinine ratio (ACR) 
testing was performed routinely by immunoassay on all urine speci-
mens that were collected in a sterile 50 ml container and refrigerated 
at 4–8 °C immediately following collection (8). BP was the average of 
three measurements taken in sitting position after 10 min rest.
collection of hospitalization and death records
Hospitalization and death records for the WPHC participants were 
matched using deterministic linkage based on hospital record num-
bers and clinical record numbers. A manual search of the Queensland 
Health hospital records systems was conducted by a registered nurse 
having experience working in the hospital records department. As 
there is no universal unique patient identifiers within Queensland, 
a mapping table linking WPHC reference number, hospital facility 
code, and local unit record number was developed. This mapping 
process commenced in January 2006 and was subsequently applied to 
the Queensland Admitted Patient Data Collection, and hospitalization 
relevant to the match unit record, facility code tuples were extracted.
Death matching was performed manually at the Queensland Registry 
of Births, Deaths and Marriages.
outcome determination
The census date for the study was determined as 1 January 2006, as 
this marked the commencement of the mapping of WPHC numbers 
to hospital unit record numbers. Any hospitalizations or deaths which 
occurred subsequent to this date were disregarded.
Hospitalizations were considered to be CHD related if they contained 
an ICD9-CM code commencing with 410, 411, 413, or 414 or an ICD9-
CM procedure code between 3,600 and 3,699, inclusive. For hospitaliza-
tions coded to ICD10, the diagnosis code range I20–I25, and procedure 
code blocks 669–679, inclusive, were used.
statistical analysis
All analyses were performed using STATA v10.1 (STATA, College 
Station, TX).
Diabetes was defined as clinical diagnosis verified by the participant’s 
medical records, or a 2-h glucose tolerance test result (blood glucose 
level >11.1 mmol/l 2-h post glucose load), or fasting blood glucose level 
(>7 mmol/l (10)). Albuminuria was defined having an abnormal spot 
urine albumin:creatinine ratio ≥2.5 mg/mmol for males and ≥3.5 mg/
mmol for females (4).
MetS were categorized using both the IDF and ATPIII criteria based 
on the available measurements of MetS components. The differences in 
 baseline characteristics between the two indigenous groups were com-
pared using t-tests or χ2-tests. The prevalence of MetS and its compo-
nents in the two subgroups were compared and the agreement κ was 
calculated.
CHD cumulative incidence was calculated using the Kaplan–Meier 
method for a range of population strata by MetS and its components.
HRs were calculated using a Cox proportional hazards model and 
adjusted for sex, age, smoking and drinking status, diabetes, and albu-
minuria to explore the independent predictive effect of MetS. The statisti-
cal significance level was set as P < 0.05.
results
The baseline health profile differs significantly between the two 
indigenous groups. TSIs had significantly higher WC, systolic 
BP, fasting blood glucose, LDL but lower triglycerides, HDL, 
albumin:creatinine ratio, and behavioral risks including smok-
ing and drinking alcohol (Table 2).
The baseline prevalence of MetS and its components defined 
by IDF and ATPIII in the two ethnic groups are summarized 
table 2 Baseline characteristics of the aboriginal and tsIs 
from north Queensland
Aborigines 
(N = 1283)
TSIs  
(N = 817) P value
Age (years) 36.6 (0.4) 37.9 (0.5) 0.02
Men, n (%) 620 (48.3) 433 (53.0) 0.04
Waist, men (cm) 89.4 (0.6) 101.3 (0.7) <0.01
Waist, women (cm) 92.1 (0.6) 103.0 (0.8) <0.01
Systolic BP (mm Hg) 128.3 (0.5) 133.8 (0.7) <0.01
Diastolic BP (mm Hg) 71.9 (0.4) 70.8 (0.5) 0.05
Glucose (mmol/l) 5.4 (0.1) 6.1 (0.1) <0.01
Triglycerides (mmol/l) 1.9 (0.04) 1.7 (0.04) 0.01
LDL (mmol/l) 2.9 (0.03) 3.2 (0.03) <0.01
HDL (mg/mmol) 1.18 (0.01) 1.11 (0.09) <0.01
ACR 15.5 (1.7) 14.4 (1.7) 0.7
Smokers (%) 822 (64.8) 415 (50.9) <0.01
Drinkers (%) 902 (72.3) 514 (64.1) <0.01
IDF MetS (%) 421 (33.0) 410 (50.3) <0.01
Values are means (standard error) or no. (%); P value from t-tests for means and 
χ2-tests for percentage.
ACR, albumin:creatinine ratio; HDL, high-density lipoprotein; IDF, International 
Diabetes Federation; LDL, low-density lipoprotein; MetS, metabolic syndrome; 
TSIs, Torres Strait Islander adults.
table 1 criteria for the definition of the metabolic syndrome (IdF, nceP-atPIII)
IDF NCEP-ATPIII
WC ≥94 cm (men), ≥80 cm (women) ≥102 cm (men), ≥88 cm (women)
Triglycerides ≥1.7 mmol/l or treatment ≥1.7 mmol/l or treatment
HDL <1.03 mmol/l (men), <1.29 mmol/l (women) <1.03 mmol/l (men), <1.29 mmol/l (women)
Blood pressure ≥135/86 mm Hg, or treatment of previously diagnosed  
hypertension
≥135/86 mm Hg, or treatment of previously diagnosed 
hypertension
Fasting glucose ≥5.6 mmol/l ≥5.6 mmol/l
According to the IDF 2005 definition, for a person to be defined as having MetS, one must have central obesity plus any two risk factors. NCEP-ATPIII is based on any 
three of the risk factors.
HDL, high-density lipoprotein; IDF, International Diabetes Federation; NCEP-ATPIII, National Cholesterol Education Program–Adult Treatment Panel III; WC, waist 
circumference.
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in Table 3. Compared with ATPIII MetS criteria, the IDF defi-
nition classified the same prevalence of MetS (33% vs. 31% in 
Aborigines and 50.3% vs. 46.9% in TSIs) and its components. 
The percentage of agreement of the two definitions was 90.9% 
in Aborigines and 94.7% in TSIs and the κ statistic was 0.79 in 
Aborigines (P < 0.001) and 0.89 in TSIs (P < 0.001).
A total of 151 CHD events (deaths and hospitalizations) were 
identified during a mean of 6.0 years of follow-up among the 
2,100 eligible subjects. A total crude CHD incidence rate was 
similar in the two groups: 11.9 cases/1,000 person years (py) 
(12.6 cases/1,000 py; 95% confidence interval: 10.3–15.3 for 
Aborigines compared with 10.9/1,000 py; 95% confidence inter-
val: 8.3–14.3 in TSIs). Among Aborigines, the CHD incidence 
rate in those classified as having MetS was 20.0 cases/1,000 py 
compared with 8.9 cases/1,000 py in normal groups. Among 
TSIs, the incidence rate in MetS patients was 16.3 cases/1,000 
py compared with 5.7 cases/1,000 py in normal subjects. The 
CHD incidence rates by MetS components in the two groups 
are summarized in Tables 4 and 5. Among the Aborigines, 
higher CHD incidence rate was associated with higher WC, 
hypertension, increased blood fasting glucose, triglycerides 
and combined hypertriglycerides and waist; whereas in TSIs, 
the significant MetS components predicting CHD were raised 
BP and raised fasting glucose. Baseline diabetes and albuminu-
ria were strong predictors of CHD incidence in both groups 
(HR for diabetes 3.2, HR for albuminuria 3.4 P < 0.001 (7)).
After adjusting for age, sex, smoking and drinking status, 
baseline diabetes, and albuminuria, Aborigines with MetS 
were approximately twice as likely to develop CHD. Increased 
WC remained associated with CHD incidence. The predictive 
effects of hypertension and increased blood glucose were 
attenuated to null after adjustment, however, those with raised 
triglycerides were 2.8 times more likely to develop CHD dur-
ing the 6-year follow-up. The combined increased triglyc-
erides and WC independently predicted CHD incidence in 
Aborigines (HR: 3.6, 95% confidence interval: 1.6–8.1), while 
those with increased triglycerides but normal waist or those 
with increased waist but normal triglycerides did not pre-
dict CHD morbidity and mortality (Table 4). In TSIs, after 
adjustment, neither MetS nor its components predicted CHD 
incidence.
dIscussIon
We found in this population a high baseline prevalence of 
MetS, by both IDF and ATPIII criteria (31–33% in Aborigines 
and 47–50% in TSI) compared to the general Australian (28.6% 
(4)) and the US (32%) populations (11). The higher MetS prev-
alence among TSI was attributable mainly to higher WC and 
fasting glucose compared to Aborigines. Yet incidence of CHD 
was similar for both groups and there were no sex differences. 
table 3 Prevalence of metabolic syndrome and components 
(IdF, nceP-atPIII criteria) by ethnicity
IDF NCEP-ATPIII
Aborigines, n 1,277 1,283
 Raised WC, n (%) 723 (56.6) 496 (38.8)
 Raised BP, n (%) 570 (44.6) 570 (44.4)
 Raised blood glucose, n (%) 240 (19.4) 240 (18.7)
 Low HDL, n (%) 603 (51.9) 603 (47.0)
 Raised triglycerides, n (%) 490 (39.5) 490 (38.2)
 MetS, n (%) 421 (33.0) 400 (31.2)
TSIs, n 816 817
 Raised WC, n (%) 652 (79.9) 522 (64.0)
 Raised BP, n (%) 452 (55.5) 452 (55.3)
 Raised blood glucose, n (%) 225 (28.2) 225 (27.5)
 Low HDL, n (%) 457 (57.8) 457 (55.9)
 Raised triglycerides, n (%) 281 (35.2) 281 (34.4)
 MetS, n (%) 410 (50.3) 383 (46.9)
In Aborigines, agreement of MetS between the two definition was 90.9%, κ was 
0.79, P < 0.001. In TSIs, agreement of MetS was 94.7%, κ was 0.89, P < 0.001.
BP, blood pressure; HDL, high-density lipoprotein; IDF, International Diabetes 
Federation; MetS, metabolic syndrome; NCEP-ATPIII, National Cholesterol Edu-
cation Program–Adult Treatment Panel III; TSIs, Torres Strait Islander adults; 
WC Waist circumference.
table 4 Incidence of chd and its association with IdF Mets 
among aborigines from north Queensland
Incidence rate 
case/1,000 py 
(95% CI)
Crude HR  
(95% CI)
Adjusted HRa 
(95% CI)
MetS
 No 8.9 (6.7–11.8) 1.0 1.0
 Yes 20.0 (15.2–26.4) 2.3 (1.5–3.4) 1.9 (1.1–3.3)
Raised waist
 No 9.6 (6.9–13.6) 1.0 1.0
 Yes 14.7 (11.5–18.8) 1.5 (1.0–2.3) 1.8 (1.0–3.2)
 Yes 16.0 (12.0–21.3) 1.5 (1.0–2.3) 1.8 (1.02–3.2)
Raised BP
 No 8.0 (5.7–11.1) 1.0 1.0
 Yes 18.2 (14.2–23.4) 2.3 (1.5–3.5) 1.5 (0.8–2.6)
Raised blood glucose
 No 10 (7.7–12.8) 1.0
 Yes 23.4 (16.6–32.9) 2.4 (1.5–3.6) 1.3 (0.6–2.8)
Low HDL
 No 12.3 (9.0–16.7) 1.0 1.0
 Yes 14.1 (10.7–18.6) 1.1 (0.7–1.7) 0.9 (0.5–1.5)
Raised triglycerides
 No 7.2 (5.1–10.1) 1.0 1.0
 Yes 21.1 (16.4–27.1) 2.9 (1.9–4.5) 2.8 (1.6–4.8)
Raised triglycerides and waist
 None 7.3 (4.6–11.6) 1.0 1.0
 Either 10.1 (7.1–14.4) 1.4 (0.8–2.5) 1.6 (0.7–3.8)
 Both 21.9 (16.4–29.3) 3.0 (1.7–5.1) 3.6 (1.6–8.1)
CI, confidence interval; CHD, coronary heart disease; IDF, International Diabetes 
Federation; MetS, metabolic syndrome; HR, hazard ratio; py, person years.
aAdjusting for age, sex, smoking and drinking status, diabetes, and albuminuria.
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Ethnic-specific cut-offs for WC or other anthropometric meas-
urements may be needed for these populations when assessing 
health risks. A study using receiver operating characteristic 
analysis to assess the discrimination power of BMI, WC, and 
waist/hip ratio for cardiometabolic risks among these popula-
tions showed neither BMI nor WC was better than waist/hip 
ratio (12).
MetS has been shown to strongly predict diabetes incidence 
in this population, with an adjusted HR of 2.7 in Aborigines 
and 2.9 in TSIs compared with absence of the MetS at base-
line (13). MetS predicts CHD morbidity and mortality in US 
and European populations with varied HRs due to varied 
adjustment of other risk factors and different methods used 
to classify MetS (6). For example, the Framingham Offspring 
study showed that a cluster of any three out of six risk factors 
including the sex-specific lowest quintile HDL, highest quintile 
of BMI, systolic BP, triglycerides, glucose, and serum total cho-
lesterol was associated with a 2.4 and 5.9 times increased risk 
of CHD in men and women, respectively (14). The European 
studies show adjusted hazard ratios for CHD mortality were 1.5 
in men and 2.5 in women with the MetS (15).
The prediction of MetS components for CHD among the two 
indigenous groups also varied, although HDL in both groups 
did not significantly predict CHD morbidity and mortality. 
Among Aborigines, increased triglycerides was the strongest 
independent predictor (HR: 2.8) followed by increased waist 
(HR: 1.8). This result is consistent with that from a meta-anal-
ysis of 10,158 incident cases among 262,525 participants in 
29 western prospective studies (16) and another meta-analy-
sis among 96,224 individuals from 26 studies in Asia-Pacific 
region (17). Both studies reported the top tertile or quintile 
triglycerides conferred 1.6–1.8 times increased risk of CHD 
morbidity and mortality after adjustment for other known 
cardiovascular risk factors including fasting glucose, total and 
HDL cholesterol.
Other studies have analyzed the prevalence of the hyper-
triglyceridemic waist phenotype and its association with 
type 2 diabetes and CVDs, indicating it could be a simpler 
alternative to MetS for CHD risk identification, especially 
among young people, before other MetS components appear 
clinically (18,19).
Aboriginal and TSI people experience disadvantage across 
a range of socioeconomic indicators including education, 
employment, income and housing (20). In 2004–2005, half of 
the adult indigenous population were current daily smokers. 
The proportion of indigenous adults drinking alcohol at high 
risk levels increased from 12% in 2001 to 17% in 2004–2005 
(20). More than half (57%) of indigenous people aged ≥15 
years were overweight or obese. Between 1995 and 2004–2005, 
rates of overweight/obesity among indigenous people aged ≥15 
years increased from 48% to 56% (20).
In summary, this study showed that MetS did not pre-
dict CHD as strongly as its components. In Aborigines, the 
combined increased triglycerides and WC better predicts 
incident CHD, whereas in TSIs, baseline diabetes and albu-
minuria could be used to detect those at risk. In both popu-
lations, greater attention is needed to alleviate risk behaviors 
and conditions, including improving the quality of the food 
supply.
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